Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children

被引:6
|
作者
Ruel, Theodore [1 ]
Ssewanyana, Isaac [2 ]
Achan, Jane [3 ]
Gasasira, Anne [4 ]
Kamya, Moses R. [3 ]
Kekitiinwa, Adeodata [5 ]
Wong, Joseph K.
Cao, Huyen [6 ]
Havlir, Diane
Charlebois, Edwin D.
机构
[1] Univ Calif San Francisco, Dept Pediat, Div Infect Dis, San Francisco, CA 94143 USA
[2] Joint Clin Res Ctr, Kampala, Uganda
[3] Makerere Univ, Fac Med, Kampala, Uganda
[4] Univ Calif Berkeley, Berkeley, CA 94720 USA
[5] Mulago Hosp, Paediat Infect Dis Clin, Baylor Coll Med, Kampala, Uganda
[6] Calif Dept Publ Hlth, Richmond, CA USA
关键词
T cell activation; Children; Antiretroviral treatment; Uganda; IMMUNE ACTIVATION; VIRAL LOAD; IMMUNOLOGICAL RESPONSE; THERAPY; IMMUNODEFICIENCY; SUBSETS; MALARIA; PROFILE; AGE;
D O I
10.1016/j.clim.2009.01.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Africans have elevated T cell activation compared to residents of Europe or the USA. Levels of T cell activation also correlate with disease progression in HIV-infected individuals. We sought to determine if treatment with antiretroviral therapy (ART) would reduce levels of T cell activation (CD38 and HLADR co-expression) in HIV-infected Ugandan children. The median CD8+ T cell activation level among 199 ART-treated children (30%) was lower than in 57 ART-naive children (45%, p<0.001), but remained higher than in 30 HIV-uninfected children (18%, p<0.001). Among ART-treated children, CD4% was inversely correlated with both CD8- (rho=-0.61, p<0.001) and CD8+ (rho=-0.38, p<0.001) T cell activation. Prospectively, CD4 recovery correlated with post-treatment CD8+ T cell activation level (p=0.008). Our data suggest that significant decreases in T cell activation accompany CD4 recovery in ART-treated HIV-infected African children, to levels that approach but do not reach those of uninfected children. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:410 / 414
页数:5
相关论文
共 50 条
  • [21] Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
    Hunt, Peter W.
    Cao, Huyen L.
    Muzoora, Conrad
    Ssewanyana, Isaac
    Bennett, John
    Emenyonu, Nneka
    Kembabazi, Annet
    Neilands, Torsten B.
    Bangsberg, David R.
    Deeks, Steven G.
    Martin, Jeffrey N.
    AIDS, 2011, 25 (17) : 2123 - 2131
  • [22] Viral Load and CD4 T Cell Percentage Predict Sleep Disturbances in HIV-Infected Children
    Okocha, I.
    Foster, S. B.
    Paul, M. E.
    Glaze, D. G.
    Reuben, J. M.
    Harris, L. L.
    Cohen, E. N.
    Lee, B.
    Kozinetz, C. A.
    Schwarzwald, H. L.
    Kline, M. W.
    Jackson, C. D.
    Ward, E. N.
    Fehlis, J. E.
    Brouwers, P. Y.
    Miller, T. L.
    Himic, L.
    Armstrong, F. D.
    Shahzeidi, S.
    Colin, A. A.
    Scott, G. B.
    Asthana, D.
    Lipshultz, S. E.
    Shearer, W. T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S17 - S17
  • [23] Age and CD4 Count at Initiation of Antiretroviral Therapy in HIV-Infected Children: Effects on Long-term T-Cell Reconstitution
    Lewis, Joanna
    Walker, A. Sarah
    Castro, Hannah
    De Rossi, Anita
    Gibb, Diana M.
    Giaquinto, Carlo
    Klein, Nigel
    Callard, Robin
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (04): : 548 - 556
  • [24] The impact of prescribed opioids on CD4 cell count recovery among HIV-infected patients newly initiating antiretroviral therapy
    Edelman, E. J.
    Gordon, K. S.
    Tate, J. P.
    Becker, W. C.
    Bryant, K.
    Crothers, K.
    Gaither, J. R.
    Gibert, C. L.
    Gordon, A. J.
    Marshall, B. D. L.
    Rodriguez-Barradas, M. C.
    Samet, J. H.
    Skanderson, M.
    Justice, A. C.
    Fiellin, D. A.
    HIV MEDICINE, 2016, 17 (10) : 728 - 739
  • [25] Cardiac Dysfunction Among Ugandan HIV-infected Children on Antiretroviral Therapy
    Namuyonga, Judith
    Lubega, Sulaiman
    Musiime, Victor
    Lwabi, Peter
    Lubega, Irene
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (03) : E85 - E88
  • [26] CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients:: the role of intravenous drug use
    Dronda, F
    Zamora, J
    Moreno, S
    Moreno, A
    Casado, JL
    Muriel, A
    Pérez-Elías, MJ
    Antela, A
    Moreno, L
    Quereda, C
    AIDS, 2004, 18 (16) : 2210 - 2212
  • [27] Decreased HIV-specific CD4 T cell proliferation in long-term HIV-infected individuals on antiretroviral therapy
    Ghanekar, SA
    Stranford, SA
    Ong, JC
    Walker, JM
    Maino, VC
    Levy, JA
    AIDS, 2001, 15 (14) : 1885 - 1887
  • [28] T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers
    Philomena Kamya
    Christos M Tsoukas
    Salix Boulet
    Jean-Pierre Routy
    Réjean Thomas
    Pierre Côté
    Mohamed-Rachid Boulassel
    Bernard Lessard
    Rupert Kaul
    Mario Ostrowski
    Colin Kovacs
    Cecile L Tremblay
    Nicole F Bernard
    AIDS Research and Therapy, 8
  • [29] T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers
    Kamya, Philomena
    Tsoukas, Christos M.
    Boulet, Salix
    Routy, Jean-Pierre
    Thomas, Rejean
    Cote, Pierre
    Boulassel, Mohamed-Rachid
    Lessard, Bernard
    Kaul, Rupert
    Ostrowski, Mario
    Kovacs, Colin
    Tremblay, Cecile L.
    Bernard, Nicole F.
    AIDS RESEARCH AND THERAPY, 2011, 8
  • [30] Assessment of chloroquine as a modulator of immune activation to improve CD4 recovery in immune nonresponding HIV-infected patients receiving antiretroviral therapy
    Routy, J-P
    Angel, J. B.
    Patel, M.
    Kanagaratham, C.
    Radzioch, D.
    Kema, I.
    Gilmore, N.
    Ancuta, P.
    Singer, J.
    Jenabian, M-A
    HIV MEDICINE, 2015, 16 (01) : 48 - 56